
[TimAlerts] $OSIR 169 MC/16.35 float 5:04 pm INPLAY Yahoo Finance Osiris Therapeutics announced that new peer-reviewed manuscript 'Human cryopreserved viable amniotic membrane inhibits the growth of bacteria associated with chronic wounds' was published in Journal of Diabetic Foot Complications (OSIR) : In the published study, antimicrobial properties of human cryopreserved viable amniotic membrane (hCVAM) were investigated. This study was conducted in the laboratory of Professor Kohn at the New Jersey Cent



